Trade SNOA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sonoma Pharmaceuticals, Inc. (SNOA) is trading at US$1.30, down 2.26% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$6.42M. Over the past 52 weeks, SNOA has traded between US$0.85 and US$4.60. On Syfe you can trade SNOA with $0 commission and add it to your watchlist.
| Previous close | US$1.33 |
|---|---|
| Market cap | US$6.42M |
| 52-week range | US$0.85 – US$4.60 |
| Volume | 28.99K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Year: 2007
Sonoma Pharmaceuticals Receives FDA Approval for Microdacyn's Expanded Indications, Packaging Options
Jun 30, 2:00 PM · MT Newswires
Sonoma Pharmaceuticals, Inc. (SNOA) stock is trading at US$1.30, -2.26% from the previous close of US$1.33.
The market cap for Sonoma Pharmaceuticals, Inc. (SNOA) stock is approximately US$6.42M.
The 52-week high for Sonoma Pharmaceuticals, Inc. (SNOA) stock is US$4.60.
The 52-week low for Sonoma Pharmaceuticals, Inc. (SNOA) stock is US$0.85.
Sonoma Pharmaceuticals, Inc. (SNOA) does not currently pay a dividend.
Stay on top of SNOA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
